Project Grant HT94252510260
Award Date
5/1/25
Completion Date
4/30/29
Dollars Obligated
$2.7M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
The federal Project Grant award in the amount of $905,863.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Illinois. The funding supports a research project titled "NEUROACTIVE STEROID BIOSYNTHESIS AND DYNAMIC GABAA RECEPTOR RECONFIGURATION IN POSTPARTUM DEPRESSION". The project aims to investigate the underlying biological mechanisms of postpartum depression, with a focus on the role of...
The University of Virginia received a three-year, $775,153 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research investigating TBI-induced disruption of brain drainage as a mechanistic driver of AD pathogenesis. Through this award, the University will support basic, applied, and advanced biomedical research aimed at transforming military and public health care by investigating medical solutions...
This $306,971 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research into the "Neurovascular Mechanisms of Depression and Implications in Cardiovascular Health" at the University of Arizona. The 2-year grant, which commenced on April 1, 2024, funds basic and applied research activities by the University to investigate the relationships between neurological, vascular, and psychological...
The U.S. Department of Defense's Defense Health Agency awarded a $323,538 Project Grant to The Johns Hopkins University to conduct research on "The Role of Autophagy in the Etiology of Postpartum Depression." This grant, provided under the Military Medical Research and Development CFDA program (12.420), supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public through innovative and impactful research. The funding...
This $300,378 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research at the University of Arizona to identify a male-specific mechanism of nociceptor sensitization that promotes migraine in active-duty service members and veterans. The research aims to develop new treatments, diagnostic tools, and clinical practice guidelines to improve the health and care of military personnel and their families. As an...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,592,860.00 to the Rector & Visitors Of The University Of Virginia (University of Virginia) to conduct an ultrasensitive proteomics research project for type 1 diabetes prediction and treatment efficacy assessment. The award period runs from January 1, 2025 to December 31, 2028. The University of Virginia, a major research institution with extensive...
The Defense Health Agency awarded a $3.755 million Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to investigate dual orexin antagonist treatment to prevent neurobehavioral sequelae of traumatic brain injury from April 1, 2023 to March 31, 2027. The Military Medical Research and Development program supports innovative medical research to improve warfighter health and transform public healthcare. Under this...
The University of Virginia will receive $748,422 under a three-year Project Grant award from the Department of the Army Medical Command. The award is funded through the Military Medical Research and Development program (CFDA 12.420).
The University will quantify the relationship between brain biomechanics and head exposures relevant to warfighters. Insights gained from this research aim to guide the development of future injury prevention technologies. Specifically, the University seeks to...
The U.S. Defense Health Agency awarded a $183,258 Project Grant to the East Bay Institute for Research & Education Inc. under the Military Medical Research and Development program (CFDA 12.420). This grant, with a performance period from March 1, 2025 to February 29, 2028, will fund a longitudinal study monitoring cognitive changes in older veterans using telehealth-enabled computerized neuropsychological assessments. The research aims to improve health outcomes for military service...
The University of Alabama will receive $749,987 under a three-year Project Grant award from the Defense Health Agency to investigate the role of environmental stressors on veteran neurocognitive aging. The grant, issued under the Military Medical Research and Development program (CFDA 12.420), will support research from May 2023 to April 2026.
The Military Medical Research and Development program aims to transform military and public health through innovative medical research. This award will...